RYETConsumer Defensive · Education & Training ServicesTicker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 3 of 100 as at 4 Nov 2026 — in the weakest quartile.
Consensus tells you what everyone already believes. The model scores Ruanyun Edai Technology, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (86): Smaller than most of the companies we track.
Issuance (2): The company has been issuing shares or taking on financing, diluting existing holders.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on RYET, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
RYET appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Nov 2026, Ruanyun Edai Technology, Inc. returned −40.0% against +14.8% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 36% of US stocks
Cheaper than 23% of US stocks
Cheaper than 78% of US stocks
Higher than 95% of US stocks
Higher than 17% of US stocks
Higher than 6% of US stocks
Higher than 5% of US stocks
Higher than 9% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Ruanyun Edai Technology, Inc. has a market value of $26.1M and an enterprise value of $25.9M.
Forward dividend yield: 0.00%, paying out 0% of earnings.
Ruanyun Edai Technology, Inc. employs 128 people.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
| Company | Market cap | TKN rank |
|---|---|---|
| RYETRuanyun Edai Technology, Inc. | $26.1M | 3 |
| GNSGenius Group Ltd. | $22.1M | 34 |
| EDTKSkillful Craftsman Education Technology Ltd. | $14.5M | 31 |
| SKILSkillsoft Corp. | $42.3M | 63 |
| CHGGChegg, Inc. | $69.9M | 61 |
| EEIQEpicQuest Education Group International Ltd. | $6.6M | 21 |
| WAFUWah Fu Education & Technology Group Ltd. | $6.4M | 25 |
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Ruanyun Edai Technology, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
BioNexus Gene Lab Corp. introduced BGLC 1Lab, a laboratory workflow product, and launched it as a controlled GeneMatrix-focused pilot at its MRNA Scientific subsidiary.
Why it matters — The item concerns a pilot at BioNexus’s subsidiary, but the provided text does not describe a direct development involving RYET.
Ruanyun Edai Technology said its Malaysian subsidiary, Formind Global Holdings, entered a marketing cooperation agreement with Taiwan-based Fangtu. Fangtu will lead local promotion and institutional customer development for the HanLink Chinese learning platform in Taiwan.
Why it matters — The agreement concerns local promotion and institutional customer development for HanLink in Taiwan.
RYET has entered the Malaysian healthcare market through an exclusive Cogni AI license agreement with BioNexus Gene Lab. The deal, which includes a license of up to 20 years and a reciprocal share exchange, entitles RYET to a 10% royalty on qualifying technology receipts and 560,000 BGLC shares as Malaysia accelerates public healthcare digitalization.
Why it matters — This expands RYET into Malaysia's digitalizing public healthcare sector and provides recurring royalty income plus equity in BioNexus Gene Lab.
Ruanyun Edai Technology, Inc. announced preliminary unaudited first-half fiscal 2027 revenue in the range of US$9.3 million to US$9.5 million. This expected first-half revenue is above its full-year revenue for each of the past two fiscal years, and the company's Formind business is advancing international partnerships in the United States, Malaysia, and Saudi Arabia.
Why it matters — A RYET watcher would care because the company's preliminary first-half revenue already exceeds its full-year figures from the past two fiscal years, indicating a significant uptick in business scale, alongside expansion into multiple international markets.
Ruanyun Edai Technology Inc. (NASDAQ: RYET) launched www.formind.group, the corporate website for Formind Group, its public-facing group identity. The launch is part of the company's global strategy for AI and education, announced from Kuala Lumpur, Malaysia.
Why it matters — RYET watchers would follow this launch as it signals the company's advancement of its group identity and global strategy focused on AI and education.
As at 4 Nov 2026, Ruanyun Edai Technology, Inc. ranks 3 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (86 of 100).
No analyst covering Ruanyun Edai Technology, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for RYET are extrapolating price history, which says nothing about the business.
Ruanyun Edai Technology, Inc. returned -40.0% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
Ruanyun Edai Technology Inc. is an education technology company focused on AI-enabled digital learning and assessment solutions in China.
The most recent item we track (GlobeNewsWire, 3 Nov 2026): "BioNexus Launches BGLC 1Lab Pilot for GeneMatrix Workflows at MRNA Scientific". BioNexus Gene Lab Corp. introduced BGLC 1Lab, a laboratory workflow product, and launched it as a controlled GeneMatrix-focused pilot at its MRNA Scientific subsidiary.
Ruanyun Edai Technology Inc. is an education technology company focused on AI-enabled digital learning and assessment solutions in China. The company provides smart campus infrastructure, education content and learning resources, examination and assessment services, AI vocational training, and campus operations and student-life services. It also serves international education and testing needs and develops AI application and enterprise solutions for institutional use. Ruanyun Edai Technology Inc. focuses on K-12 education, supporting schools, teachers, and students with tools designed to improve teaching, homework management, testing, and academic administration. Its current business mix centers on campus and education services, digital learning platforms, and AI-driven workflow and content recognition applications. Headquartered in Nanchang, China and founded in 2012, Ruanyun Edai Technology Inc. plays a niche role in the broader education services market by combining software, services, and artificial intelligence for schools and education providers.
CEO Ms. Yan Fu · 128 employees · China · https://www.ruanyuntech.com
